RECENT NEWS

London Medical Laboratory (LML) has improved its efficiency and enhanced annual revenue growth by deploying Cirdan’s next-generation laboratory information system, ULTRA. ULTRA improves the quality of patient care by delivering more timely and accurate results to both clinicians and patients.

HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.

In his Spring Budget today, 15 March, the Chancellor of the Exchequer, Jeremy Hunt has announced future changes for the Medicines and Healthcare products Regulatory Agency (MHRA).

Owlstone Medical the developer of Breath Biopsy for applications in early disease detection and precision medicine, has entered into a research agreement with Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology.

Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, diagnostics and pharma to improve their quality control (QC) process.

The UK Transfusion Laboratory Collaborative (UKTLC) has revised its minimum standards for 2023, with an abridged version now available on the Serious Hazards Of Transfusion (SHOT) website.

The 2023 Advancing Healthcare Awards has unveiled its shortlist ahead of the awards lunch and presentation ceremony taking pace on 21 April. The awards recognise and celebrate the work of allied health professionals, healthcare scientists and those who work alongside them in support roles, leading innovative healthcare practice across the UK.

Thermo Fisher Scientific Microbiology has achieved International Organization for Standardization (ISO) 17034 certification, making it an accredited reference material (RM) manufacturer of certified reference material (CRM) quality control products.

Paige and Leica Biosystems have expanded their partnership to enhance the use of digital pathology workflows at hospitals and laboratories around the world. Building upon the existing partnership, Leica Biosystems has selected Paige as the preferred provider of software-as-a-service (SaaS) digital pathology image management and viewing software along with diverse embedded AI solutions for its line of Aperio GT 450 digital pathology slide scanners.

Proscia, a leading provider of digital and computational pathology solutions, has announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq Dx to modernise its pathology operations.

The biotechnology company Neogap and the cancer diagnostics company Simsen Diagnostics have initiated a collaboration aimed at improving personalised cancer diagnostics by examining circulating tumour DNA in the blood of patients participating in Neogap's phase I/II clinical trial. The goal is to develop more precise and effective diagnostic tools for cancer.

Agilent Technologies has announced an end-to-end solution for digital pathology that brings together best-in-class products from Agilent, Visiopharm, Proscia, and Hamamatsu Photonics K.K. The announcement was made at the USCAP 112th Annual Meeting held 11-16 March in New Orleans, Louisiana.

New artificial intelligence (AI) software from Paige that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.

Glasgow-based R-Biopharm Rhone, manufacturer and distributor of analytical test kits, has become the first company in its sector to be certified as carbon neutral.

Fujifilm Healthcare Americas Corporation, a provider of enterprise imaging and informatics solutions, will showcase its newly branded Synapse Pathology (formerly Dynamyx) at the forthcoming United States and Canadian Academy of Pathology (USCAP) annual meeting in New Orleans.

Proteomedix, a Swiss diagnostics company committed to advance prostate cancer care, has announced that new results evaluating Proclarix in combination with imaging were published in BJU International.

Fluxergy, a medical diagnostic company focused on multiplex, multimodal point-of-care testing, has announced that it has acquired certain employees and assets and licensed electrochemical biosensing technology from InnaMed, Inc. including the HomeLab device and software.

Agilent Technologies has announced a multi-year distribution agreement with digital pathology firm Proscia to offer a comprehensive digital diagnostic pathology system. Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower laboratories to transform diagnostic efficiency and quality.

Professor Rajpoot, Director of the Tissue Image Analytics (TIA) Centre at the University of Warwick, has been announced as the new GSK Chair of Computational Pathology at the University of Warwick.

Biotechnology company Roquefort Therapeutics has announced the formation of its Scientific Advisory Board (SAB).